Newborn Screening for CF across the Globe—<i>Where Is It Worthwhile</i>?
Newborn screening (NBS) for cystic fibrosis (CF) has been performed in many countries for as long as four decades and has transformed the routine method for diagnosing this genetic disease and improved the quality and quantity of life for people with this potentially fatal disorder. Each region has...
Main Authors: | Virginie Scotet, Hector Gutierrez, Philip M. Farrell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/6/1/18 |
Similar Items
-
Evidence for decline in the incidence of cystic fibrosis: a 35-year observational study in Brittany, France
by: Scotet Virginie, et al.
Published: (2012-03-01) -
Psychological Impact of NBS for CF
by: Jane Chudleigh, et al.
Published: (2020-03-01) -
The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the <i>CFTR</i> Gene Discovery
by: Virginie Scotet, et al.
Published: (2020-05-01) -
Newborn Screening Program for Cystic Fibrosis in Cuba: Three Years’ Experience
by: Elisa M. Castells, et al.
Published: (2023-06-01) -
Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis
by: Schäfer, Jürgen, et al.
Published: (2018)